0000950170-24-073614.txt : 20240614 0000950170-24-073614.hdr.sgml : 20240614 20240614160211 ACCESSION NUMBER: 0000950170-24-073614 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240611 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 241044612 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 8-K 1 agen-20240611.htm 8-K 8-K
false000109897200010989722024-06-112024-06-11

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 11, 2024

 

 

AGENUS INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

000-29089

06-1562417

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3 Forbes Road

 

Lexington, Massachusetts

 

02421

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 781 674-4400

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.01 par value per share

 

AGEN

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

Agenus Inc. (the “Company”) held its Annual Meeting of Stockholders on June 11, 2024 (the “Annual Meeting”). A total of 14,463,269 shares of common stock, representing 69% of the shares outstanding and eligible to vote and constituting a quorum, were present at the Annual Meeting or represented by valid proxies. At the Annual Meeting, the Company’s stockholders voted on the following matters, which are described in detail in the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on April 26, 2024: (i) to elect Susan Hirsch as a Class III director for a term of three years expiring at the 2027 Annual Meeting of Stockholders (“Proposal 1”); (ii) to approve an amendment to the Company’s Amended and Restated 2019 Equity Incentive Plan (“Proposal 2”); (iii) to approve an amendment to the Company’s Amended and Restated Directors’ Deferred Compensation Plan (as amended) to increase the number of shares of common stock authorized for issuance thereunder from 38,750 shares to 63,750 shares (“Proposal 3”); (iv) approve, in a non-binding advisory vote, the compensation of the Company’s named executive officers (“Proposal 4”); and (v) to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 (“Proposal 5”).

 

The Company’s stockholders approved the Class III director nominee recommended for election in Proposal 1 at the Annual Meeting.

 

The votes cast at the Annual Meeting were as follows:

Class III Director Nominee

For

Withheld

Broker Non-Votes

Susan Hirsch

9,258,873

1,018,060

4,186,336

 

The Company’s stockholders approved Proposal 2. The votes cast at the Annual Meeting were as follows:

 

 

 

 

 

 

 

For

Against

Abstain

Broker Non-Votes

7,717,389

2,466,405

93,139

4,186,336

 

The Company’s stockholders approved Proposal 3. The votes cast at the Annual Meeting were as follows:

 

 

 

 

 

 

 

For

Against

Abstain

Broker Non-Votes

9,009,980

1,206,077

60,876

4,186,336

 

The Company’s stockholders approved Proposal 4. The votes cast at the Annual Meeting were as follows:

 

 

 

 

 

 

 

For

Against

Abstain

Broker Non-Votes

8,811,608

1,193,315

 

272,010

4,186,336

 

The Company’s stockholders approved Proposal 5. The votes cast at the Annual Meeting were as follows:

For

Against

Abstain

Broker Non-Votes

13,609,986

687,217

 

166,066

N/A

In consideration of the results of the vote on Proposal 5, the Company has determined that it will conduct the advisory vote annually.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

Date:

June 14, 2024

By:

/s/ Christine M. Klaskin

 

 

 

Christine M. Klaskin, VP Finance

 

 EX-101.SCH 2 agen-20240611.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document And Entity Information
Jun. 11, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 11, 2024
Entity Registrant Name AGENUS INC.
Entity Central Index Key 0001098972
Entity Emerging Growth Company false
Entity File Number 000-29089
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 06-1562417
Entity Address, Address Line One 3 Forbes Road
Entity Address, City or Town Lexington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02421
City Area Code 781
Local Phone Number 674-4400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value per share
Trading Symbol AGEN
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports agen-20240611.htm agen-20240611.xsd http://xbrl.sec.gov/dei/2024 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "agen-20240611.htm": { "nsprefix": "agen", "nsuri": "http://www.agenusbio.com/20240611", "dts": { "inline": { "local": [ "agen-20240611.htm" ] }, "schema": { "local": [ "agen-20240611.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_cca3bc91-39ed-4a18-ac60-d949160507a9", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "agen-20240611.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_cca3bc91-39ed-4a18-ac60-d949160507a9", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "agen-20240611.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.agenusbio.com/20240611/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 12 0000950170-24-073614-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-073614-xbrl.zip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end XML 14 agen-20240611_htm.xml IDEA: XBRL DOCUMENT 0001098972 2024-06-11 2024-06-11 false 0001098972 8-K 2024-06-11 AGENUS INC. DE 000-29089 06-1562417 3 Forbes Road Lexington MA 02421 781 674-4400 false false false false Common Stock, $0.01 par value per share AGEN NASDAQ false